Northwest Biotherapeutics Company
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Industry:
Dendritic Cells
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Investors Number:
1
Headquarters:
Bethesda, Maryland, United States
Employee Number:
11-50
Total Funding:
169400000
Founded Date:
1998-01-01
Last Funding Type:
Post-IPO Debt
Last Funding Date:
2021-11-22